The merger of Penn State Hershey Medical Center and Pinnacle Health System in Pennsylvania can be blocked by the Federal Trade Commission, according to a ruling by a federal appeals court judge, reversing a decision in May that went against the FTC.

The FDA approved a new drug called Amjevita Sept. 23. The drug, adalimumab-atto, is made by the California-based company Amgen and is biosimilar to the AbbVie drug Humira (adalimumab). 

Health and Human Services (HHS) Secretary Sylvia Burwell doesn’t have much time left in her position. Her boss’s second presidential term is almost over, so her role as steward of his hallmark policy, the Affordable Care Act (ACA), will be over too. 

Sept. 23 was the final day for insurers to confirm their health insurance exchange participation in the states relying on the federal Healthcare.gov marketplace. Last-minute decisions by two insurers will affect coverage options in Delaware, Nebraska, Pennsylvania and West Virginia. 

Donald Trump has been telling supporters and reporters that President Barack Obama is trying to delay open enrollment on health insurance exchanges until after Election Day—but the start date has been set in stone for months.

The average monthly premium for Medicare Advantage enrollees will drop about 4 percent, or $1.19, to $31.40, according to a new estimate released by CMS.

The state of health care would look dramatically different under a Hillary Clinton presidency than it would under Donald Trump, according to a new report from the Commonwealth Fund and the RAND Corporation.

Only some doctors are qualified to prescribe certain drugs that help patients deal with withdrawal symptoms or overdose dangers from opioids. But they might not be treating as many patients as possible to make a dent in the nation’s opioid crisis.